Welcome to our dedicated page for HEALTHPEAK PROPERTIES SEC filings (Ticker: DOC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Healthpeak Properties, Inc. filings document the regulatory record of a Maryland REIT focused on healthcare discovery and delivery real estate. Form 8-K reports furnish quarterly and annual financial results, supplemental operating information, Regulation FD materials, non-GAAP reconciliations, and material agreements tied to credit facilities and other financing activity.
Proxy and annual-meeting filings describe board elections, shareholder voting results, executive compensation, and governance matters. The filing record also covers capital-structure disclosures for Healthpeak and Healthpeak OP, including unsecured term loan amendments, delayed-draw financing, senior notes, and related subsidiary financing activity.
Sandstrom Katherine M reported acquisition or exercise transactions in this Form 4 filing.
HEALTHPEAK PROPERTIES, INC. director Katherine M. Sandstrom received an equity award of 9,744 shares of Common Stock on May 6, 2026, recorded at a price of $0.00 per share as a grant rather than an open-market trade. According to the footnote, these restricted stock units vest in full on the earlier of the first anniversary of the May 6, 2026 grant date or the Company's next annual meeting of stockholders. Following this award, Sandstrom directly holds a total of 76,669 shares of the company's stock.
Healthpeak Properties, Inc. reported solid first‑quarter 2026 growth while reshaping its portfolio. Total revenue reached $752.9 million, up from $702.9 million a year earlier, driven by outpatient medical, lab, and senior housing properties. Net income rose to $199.7 million from $50.1 million, and diluted EPS increased to $0.28 from $0.06.
The company completed the Janus Living, Inc. IPO, issuing 48.3 million Class A‑1 shares to public investors for $966 million in gross proceeds, leaving Healthpeak with 81.6% voting and economic rights and $560.4 million of noncontrolling interest. Healthpeak also bought out a JV partner’s 46.5% stake in the SWF Senior Housing JV for $312 million and acquired additional senior housing portfolios in Georgia, Florida, and Washington plus lab land in Massachusetts.
Operating cash flow was $260.9 million, while the company deployed $638.6 million on investing activities, largely for acquisitions and development. Cash and cash equivalents rose to $1.17 billion, supported by active use of a $2.0 billion commercial paper program and $1.25 billion of term loans alongside $6.9 billion of senior unsecured notes.
Healthpeak Properties, Inc. reported strong first quarter 2026 results and raised its full-year earnings outlook. Net income applicable to common shares rose to $193.5 million, or $0.28 per share, on total revenues of $753 million. Diluted Nareit FFO was $0.42 per share and diluted FFO as Adjusted was $0.45 per share.
The quarter was driven by the successful IPO of Janus Living, which generated approximately $880 million of net proceeds and is 81.6% owned by Healthpeak. Healthpeak contributed $714 million of senior housing acquisitions to Janus and Janus reported first quarter FFO as Adjusted of $0.23 per share with revenue and Adjusted EBITDAre up 35% and 42% year over year.
Healthpeak executed $267 million of recapitalizations, dispositions, and loan repayments, including selling an 80% interest in a six-property outpatient medical portfolio to Blackstone for about $170 million, and repurchased 5.9 million shares for roughly $100 million. Net Debt to Adjusted EBITDAre was 5.4x. The company declared second quarter common dividends totaling $0.305 per share and updated 2026 guidance, lifting diluted EPS to $0.46–$0.50 and FFO as Adjusted per share to $1.71–$1.75.
Healthpeak Properties, Inc. held its annual stockholder meeting on April 30, 2026, with 632,249,628 common shares represented, about 91% of shares entitled to vote, establishing a quorum. All director nominees were elected with strong support, generally between 96.4% and 99.8% of votes cast, and the Board size was set at nine members.
Stockholders approved the advisory vote on 2025 executive compensation, with 522,635,664 votes in favor and 89.2% of votes cast supporting the proposal. They also ratified the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 97.2% of votes cast in favor.
Vanguard Capital Management reported beneficial ownership of 51,643,591 shares of Healthpeak Properties Inc Common Stock. The filing states this equals 7.42% of the class and shows sole dispositive power for 51,643,591 shares and sole voting power for 6,424,664 shares.
Vanguard Portfolio Management reports beneficial ownership of 58,209,788 shares of Healthpeak Properties Inc common stock, representing 8.37% of the class as reported for the period ended 03/31/2026. Vanguard discloses sole dispositive power over those 58,209,788 shares and sole voting power for 83,889 shares. The filing states these holdings include securities held for Vanguard funds and managed accounts and that no single outside person holds more than 5% of the class. The filing is signed by Ashley Grim on 04/29/2026.
Healthpeak Properties Inc — The Vanguard Group filed Amendment No. 18 to a Schedule 13G/A reporting 0 shares beneficially owned, representing 0% of the common stock. The filing explains an internal realignment effective January 12, 2026, that disaggregated certain Vanguard subsidiaries' holdings.
The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026. It states that Vanguard and related entities have the right to receive dividends or sale proceeds for accounts reported, and that no single other person holds more than 5% of the class.
Healthpeak Properties, Inc. amended several credit agreements in connection with the Janus Living, Inc. IPO. The company added a new $400.0 million senior unsecured delayed draw term loan facility with a five-year maturity and increased maximum aggregate borrowing capacity under its term loan credit agreement from $1.5 billion to $2.0 billion.
Loans under the new facility bear interest at a base rate or SOFR-based rates plus a margin tied to Healthpeak OP’s debt ratings, initially 0.00% for base rate loans and 0.80% for Term SOFR and Daily SOFR loans. After these changes, unused borrowing capacity under the term loan agreement, including the delayed draw commitments, was $750.0 million.
Janus Living, Inc. insiders have reported their initial ownership positions. Entities associated with the company indirectly hold 75,917,780 OP Units in Janus Living OP, LLC, which are linked one-for-one to Class A-1 Common Stock. Janus Member LLC also indirectly holds 138,816,246 shares of Class A-1 Common Stock and 75,917,780 shares of Class A-2 Common Stock, reflecting substantial voting and economic interests.
Healthpeak Properties, Inc. is asking stockholders to vote at its virtual 2026 annual meeting on three items: electing nine directors, approving 2025 executive compensation on an advisory basis, and ratifying Deloitte & Touche LLP as independent auditor for 2026.
The company, an S&P 500 healthcare REIT focused on lab, outpatient medical, and senior housing real estate, highlights 2025 Nareit FFO of $1.81 per share, Diluted FFO as Adjusted of $1.84 per share, 4% merger‑combined same‑store cash (adjusted) NOI growth, and a $1.22 annualized dividend per share with a 7% yield. Net debt to Adjusted EBITDAre averaged 5.2x in 2025.
The proxy emphasizes an independent Board (with an independent Chair), committee refreshment, a 15‑year director term limit, proxy access, and strong attendance. Executive pay is positioned as pay‑for‑performance, using base salary, a STIP tied mainly to normalized FFO per share and leverage, and a largely performance‑based LTIP driven by relative total stockholder return from 2025–2027.